Effect of Cytochrome P450 3A4 Inducers on the Pharmacokinetic, Pharmacodynamic and Safety Profiles of Bortezomib in Patients with Multiple Myeloma or Non-Hodgkinʼs Lymphoma
2011; Adis, Springer Healthcare; Volume: 50; Issue: 12 Linguagem: Inglês
10.2165/11594410-000000000-00000
ISSN1179-1926
AutoresAndrzej Hellmann, Simon Rule, Jan Walewski, Ofer Shpilberg, Huaibao Feng, Helgi van de Velde, Hamina Patel, Donna Skee, Suzette Girgis, Vernon Louw,
Tópico(s)HIV/AIDS drug development and treatment
Referência(s)